Dr. Bruno Scheller and Dr. C. Michael Gibson Discuss: One-year Outcomes of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons Versus POBA in Coronary In-Stent Restenosis Lesions November 6, 2021 Disclosures: TBA
Dr. Roberto Galea and Dr. C. Michael Gibson Discuss: SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure November 6, 2021 Disclosures: TBA
Dr. Dominick Angiolillo and Dr. C. Michael Gibson Discuss: Update on Vazalore: A Novel Aspirin Formulation November 5, 2021 Disclosures: TBA
Dr. Pieter C. Smits and Dr. C. Michael Gibson Discuss: MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy – Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk November 5, 2021 Disclosures: TBA
Dr. Pavel Osmancik and Dr. C. Michael Gibson Discuss: PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation November 5, 2021 Disclosures: TBA
Dr. DJ Lakkireddy and Dr. C. Michael Gibson Discuss: AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion November 5, 2021 Disclosures: TBA
Dr. David Cohen and Dr. C. Michael Gibson Discuss: Going with the Flow November 4, 2021 Disclosures: TBA
Dr. Ajay Kirtane and Dr. Yazan Daaboul: RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration November 4, 2021 Disclosures: TBA
Dr. Haibo Jia, Jingbo Hou, and Dr. C. Michael Gibson Discuss: EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency November 4, 2021 Disclosures: TBA
Dr. David E. Kandzari and Dr. C. Michael Gibson Discuss: OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG November 4, 2021 Disclosures: TBA
